title: Second wave anti-HCV protease inhibitors: too little too late?
authors.affiliation: Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy; Università degli Studi di Milano, Milano, Italy.
authors.forename: Stella
authors.initials: S
authors.lastname: De Nicola
authors.forename: Alessio
authors.initials: A
authors.lastname: Aghemo
mesh_terms: D005260:Female; D016174:Hepacivirus / Q000235:genetics*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D007769:Lactams / Q000627:therapeutic use*; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D019438:Ritonavir / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D016898:Interferon-alpha; D007769:Lactams; D013449:Sulfonamides; D011092:Polyethylene Glycols; D019438:Ritonavir